| Abstract |
【Abstract】Objective: To study the influence of the clinical curative effect of modified morita therapy combined the merit on chronic schizophrenia patients. Methods: From April 2016 to December 2016, Selected 80 cases of chronic schizophrenia patients to treat with research, were randomly divided into morita vipassana integration group and morita group(n= 40 cases). Both groups used systematic routine antipsychotic drug to treat, nursing and morita therapy, morita vipassana integrated therapy group on the basis of this progress inline view. After treatment 3 month, 6 month before treatment, respectively, with Positive and Negative symptoms Scale (PANSS), the length of the mental patient social function rating Scale (SSPI), self-knowledge and treatment attitude questionnaire (ATIQ) Scale to assess the efficacy of two groups of patients. Results: Two groups on 3 month and 6 month after treatment in patients with PANSS score was significantly lower than before treatment, and 3 month and 6 month after treatment the PANSS score of morita vipassana integration group was lower than that of morita group, with statistically significant (P < 0.05); 3 month and 6 month after treatment SSPI score of both groups were significantly higher than those before treatment, and 3 month and 6 month after treatment, the SSPI score morita of vipassana integration group was significantly higher than that of morita group, with statistical significance (P < 0.05); 3 month and 6 month after treatment, ATIQ score of both groups were significantly higher than those before treatment, and 3 month and 6 month after treatment, ATIQ score of morita vipassana integration group was significantly higher than that of morita group, with statistical significance (P < 0.05). Conclusion: In patients with chronic schizophrenia with modified morita therapy within the joint view therapy can well improve the patients symptoms, social function and cognitive ability, improve the quality of life of the patients.
|